Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10054)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun HY, Sheng WH, Tsai MS, Lee KY, Chang SY, Hung CC. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review. World J Gastroenterol 2014; 20(40): 14598-14614 [PMID: 25356024 DOI: 10.3748/wjg.v20.i40.14598] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14598.htm |
| Number | Citing Articles |
| 1 |
Yu-Shan Huang, Hsin-Yun Sun, Sui-Yuan Chang, Yu-Chung Chuang, Aristine Cheng, Sung-Hsi Huang, Yi-Chia Huang, Guan-Jhou Chen, Kuan-Yin Lin, Yi-Ching Su, Wen-Chun Liu, Chien-Ching Hung. Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection. Hepatology International 2019; 13(4): 431 doi: 10.1007/s12072-019-09953-4
|
| 2 |
Kenneth E. Sherman, Marion G. Peters, David Thomas. Human immunodeficiency virus and liver disease: A comprehensive update. Hepatology Communications 2017; 1(10): 987 doi: 10.1002/hep4.1112
|
| 3 |
Samuel R. Schnittman, Roland Zepf, Jennifer Cocohoba, David Sears. Brief Report: Heplisav-B Seroprotection in People With HIV: A Single-Center Experience. JAIDS Journal of Acquired Immune Deficiency Syndromes 2021; 86(4): 445 doi: 10.1097/QAI.0000000000002573
|
| 4 |
Vincenzo Malagnino, Elisabetta Teti, Mirko Compagno, Luigi Coppola, Romina Salpini, Valentina Svicher, Monica Basso, Giuliana Battagin, Sandro Panese, Maria Cristina Rossi, Renzo Scaggiante, Daniela Zago, Marco Iannetta, Saverio Giuseppe Parisi, Massimo Andreoni, Loredana Sarmati. HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. Microorganisms 2021; 9(2): 396 doi: 10.3390/microorganisms9020396
|
| 5 |
Lijun Gu, Yang Han, Yijia Li, Ting Zhu, Xiaojing Song, Ying Huang, Feifei Yang, Shuo Guan, Jing Xie, Jin Gohda, Noriaki Hosoya, Ai Kawana-Tachikawa, Wenjun Liu, George Fu Gao, Aikichi Iwamoto, Taisheng Li, Takaomi Ishida, D William Cameron. Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China. PLOS ONE 2015; 10(8): e0134539 doi: 10.1371/journal.pone.0134539
|
| 6 |
Emmanuel O Ugwu, George U Eleje, Angela O Ugwu, Uchenna I Nwagha, Joseph I Ikechebelu, Uchenna A Umeh, Henrietta U Okafor. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD013653
|
| 7 |
Patrick Nadol, Siobhan O’connor, Hao Duong, Linh-Vi N. Le, Pham Hong Thang, Tran Hong Tram, Hoang Thi Thanh Ha, Michelle S. Mcconnell, Jeff Partridge, John Kaldor, Matthew Law, Tuan Anh Nguyen, Anna Kramvis. Findings from Integrated Behavioral and Biologic Survey among Males Who Inject Drugs (MWID) — Vietnam, 2009–2010: Evidence of the Need for an Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus. PLOS ONE 2015; 10(2): e0118304 doi: 10.1371/journal.pone.0118304
|
| 8 |
Emmanuel O Ugwu, George U Eleje, Angela O Ugwu, Uchenna I Nwagha, Joseph I Ikechebelu, Uchenna A Umeh, Henrietta U Okafor. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus. Cochrane Database of Systematic Reviews 2023; 2023(6) doi: 10.1002/14651858.CD013653.pub2
|
| 9 |
Tania H. Mulherkar, Daniel Joseph Gómez, Grace Sandel, Pooja Jain. Co-Infection and Cancer: Host–Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses. Viruses 2022; 14(9): 2037 doi: 10.3390/v14092037
|
| 10 |
Bei Jiang, Rui Su, Doudou Ren, Xiaoya Zheng, Yu Cao, Yuqiang Mi, Fengmei Wang, Ping Ma. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients. Virus Research 2020; 290: 198117 doi: 10.1016/j.virusres.2020.198117
|
| 11 |
Marina B. Klein, Keri N. Althoff, Yuezhou Jing, Bryan Lau, Mari Kitahata, Vincent Lo Re, Gregory D. Kirk, Mark Hull, H. Nina Kim, Giada Sebastiani, Erica E.M. Moodie, Michael J. Silverberg, Timothy R. Sterling, Jennifer E. Thorne, Angela Cescon, Sonia Napravnik, Joe Eron, M. John Gill, Amy Justice, Marion G. Peters, James J. Goedert, Angel Mayor, Chloe L. Thio, Edward R. Cachay, Richard Moore. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Clinical Infectious Diseases 2016; : ciw531 doi: 10.1093/cid/ciw531
|
| 12 |
Yimam Getaneh, Fentabil Getnet, Minilik Demissie Amogne, Lingjie Liao, Feng Yi, Yiming Shao. Burden of hepatitis B virus and syphilis co-infections and its impact on HIV treatment outcome in Ethiopia: nationwide community-based study. Annals of Medicine 2023; 55(2) doi: 10.1080/07853890.2023.2239828
|
| 13 |
Uroš Karić, Ivana Milošević, Ivana Pešić-Pavlović, Dubravka Salemović, Milan Stojković, Djordje Jevtović. The treatment outcome of chronic HBV infection among HBV/HIV co-infected and HBV mono-infected patients. International Journal of STD & AIDS 2020; 31(1): 38 doi: 10.1177/0956462419879843
|
| 14 |
Rongrong Yang, Xien Gui, Hengning Ke, Yong Xiong, Shicheng Gao. Long‐term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co‐infected Chinese. Journal of Viral Hepatitis 2020; 27(2): 127 doi: 10.1111/jvh.13212
|
| 15 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 16 |
Yu-Shan Huang, Sui-Yuan Chang, Wang-Huei Sheng, Hsin-Yun Sun, Kuan-Yeh Lee, Yu-Chung Chuang, Yi-Ching Su, Wen-Chun Liu, Chien-Ching Hung, Shan-Chwen Chang, Ming-Lung Yu. Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLOS ONE 2016; 11(12): e0169228 doi: 10.1371/journal.pone.0169228
|
| 17 |
Yimam Getaneh, SitiQ. Khairunisa, Dominicus Husada, Kuntaman Kuntaman, Maria I. Lusida. Burden of HIV, HBV and syphilis among children in urban Ethiopia: Community‐based cross‐sectional study. HIV Medicine 2023; 24(6): 676 doi: 10.1111/hiv.13457
|
| 18 |
Mohsen Navari, Maryam Etebari, Giulia De Falco, Maria R. Ambrosio, Davide Gibellini, Lorenzo Leoncini, Pier Paolo Piccaluga. The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma. Frontiers in Microbiology 2015; 6 doi: 10.3389/fmicb.2015.00556
|
| 19 |
Priya D. Farooq, Kenneth E. Sherman. Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV. Current HIV/AIDS Reports 2019; 16(5): 395 doi: 10.1007/s11904-019-00461-6
|
| 20 |
Kainat Ahmed, Sudhakar Jha. Oncoviruses: How do they hijack their host and current treatment regimes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(5): 188960 doi: 10.1016/j.bbcan.2023.188960
|
| 21 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|
| 22 |
Evaristus Adesina, Oladokun Omojola, David Imhonopi, Babatunde Adeyeye, Charity Ben-Enukora, Scholastica Anake. Information Sources, Knowledge and Practice Towards HIV/ Hepatitis B Co-Infection In Lagos, Nigeria. International Journal of Biology and Biomedical Engineering 2021; 15: 285 doi: 10.46300/91011.2021.15.34
|
| 23 |
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro, G. Tosone. Prevention of hepatitis B virus infection: from the past to the future. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(6): 1059 doi: 10.1007/s10096-015-2341-x
|
| 24 |
A. V. Semenov, Yu. V. Ostankova, E. N. Serikova, E. B. Zueva, Areg A. Totolian. Optimization of the algorithm diagnosis
chronic hepatitis B markers in patients with newly diagnosed HIV infection. Russian Clinical Laboratory Diagnostics 2020; 65(9): 574 doi: 10.18821/0869-2084-2020-65-9-574-579
|
| 25 |
Maria Isaguliants, Ekaterina Bayurova, Darya Avdoshina, Alla Kondrashova, Francesca Chiodi, Joel Palefsky. Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers 2021; 13(2): 305 doi: 10.3390/cancers13020305
|
| 26 |
Yu-Shan Huang, Hsin-Yun Sun, Sui-Yuan Chang, Yu-Chung Chuang, Yi-Ching Su, Wen-Chun Liu, Chien-Ching Hung. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus. International Journal of Antimicrobial Agents 2022; 60(5-6): 106682 doi: 10.1016/j.ijantimicag.2022.106682
|
| 27 |
Edina Amponsah‐Dacosta, Selokela G. Selabe, Maphahlaganye J. Mphahlele. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co‐infected patients. Journal of Medical Virology 2018; 90(2): 291 doi: 10.1002/jmv.24956
|
| 28 |
Dong‐Ze Ji, Xiao‐Yu Pang, Dan‐Ting Shen, Shu‐Na Liu, Hemant Goyal, Hua‐Guo Xu. Global prevalence of occult hepatitis B: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(5): 317 doi: 10.1111/jvh.13660
|
| 29 |
|
| 30 |
Tao Sun, Li Liu, Ao Wu, Yujiao Zhang, Xiaofang Jia, Lin Yin, Hongzhou Lu, Lijun Zhang. iTRAQ based investigation of plasma proteins in HIV infected and HIV/HBV coinfected patients — C9 and KLK are related to HIV/HBV coinfection. International Journal of Infectious Diseases 2017; 63: 64 doi: 10.1016/j.ijid.2017.08.006
|
| 31 |
Motswedi Anderson, Simani Gaseitsiwe, Sikhulile Moyo, Kerapetse P. Thami, Terence Mohammed, Ditiro Setlhare, Theresa K. Sebunya, Eleanor A. Powell, Joseph Makhema, Jason T. Blackard, Richard Marlink, Max Essex, Rosemary M. Musonda. Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases 2016; 3(3) doi: 10.1093/ofid/ofw140
|
| 32 |
Livia Melo Villar, Helena Medina Cruz, Moyra Machado Portilho, Jakeline Ribeiro Barbosa, Ana Carolina Fonseca da Mendonça, Geane Lopes Flores. Public Health - Emerging and Re-emerging Issues. 2018; doi: 10.5772/intechopen.79174
|
| 33 |
Malihe Naderi, Seyed Masoud Hosseini, Naser Behnampour, Iraj Shahramian, Abdolvahab Moradi. Determining the Prevalence of Hepatitis Delta Virus, Hepatitis C Virus, and HIV Among Mothers and Infants with Hepatitis B Virus Chronic Infection. Jundishapur Journal of Microbiology 2022; 15(7) doi: 10.5812/jjm-127879
|
| 34 |
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara. Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview. International Journal of Molecular Sciences 2023; 24(11): 9624 doi: 10.3390/ijms24119624
|
| 35 |
Rachel Presti, Giuseppe Pantaleo. Infectious Diseases. 2017; : 837 doi: 10.1016/B978-0-7020-6285-8.00092-7
|
| 36 |
Sukesh Kumar Bajire, Sandesh G. Sanjeeva, Renjith P. Johnson, Rajesh P. Shastry. Antiviral and Antimicrobial Smart Coatings. 2023; : 87 doi: 10.1016/B978-0-323-99291-6.00009-8
|
| 37 |
Linda Wittkop. End-Stage Liver Disease in HIV Infection: An Avoidable Burden?. Clinical Infectious Diseases 2016; : ciw537 doi: 10.1093/cid/ciw537
|
| 38 |
Thomas Weitzel, Fernanda Rodríguez, Luis Miguel Noriega, Alejandra Marcotti, Luisa Duran, Carla Palavecino, Lorena Porte, Ximena Aguilera, Marcelo Wolff, Claudia P. Cortes, Yury E. Khudyakov. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey. PLOS ONE 2020; 15(1): e0227776 doi: 10.1371/journal.pone.0227776
|
| 39 |
Yu-Lin Lee, Kuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, Chia-Jui Yang, Mao-Song Tsai, Hung-Jen Tang, Te-Yu Lin, Ning-Chi Wang, Yi-Chien Lee, Shih-Ping Lin, Yu-Shan Huang, Hsin-Yun Sun, Jun-Yu Zhang, Wen-Chien Ko, Shu-Hsing Cheng, Yuan-Ti Lee, Chun-Eng Liu, Chien-Ching Hung, Yury E Khudyakov. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLOS ONE 2017; 12(10): e0186338 doi: 10.1371/journal.pone.0186338
|
| 40 |
Yi‐Chia Huang, Szu‐Min Hsieh, Wang‐Huei Sheng, Yu‐Shan Huang, Kuan‐Yin Lin, Guan‐Jhou Chen, Shang‐Ping Yang, Wen‐Chun Liu, Yi‐Ching Su, Hsin‐Yun Sun, Chien‐Ching Hung, Shan‐Chwen Chang. Serological responses to revaccination against HBV in HIV‐positive patients born in the era of nationwide neonatal HBV vaccination. Liver International 2018; 38(11): 1920 doi: 10.1111/liv.13721
|
| 41 |
Annacarla Chiesa, Emmanuel Ochola, Letizia Oreni, Paolo Vassalini, Giuliano Rizzardini, Massimo Galli, Jason Blackard. Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?. PLOS ONE 2020; 15(11): e0242278 doi: 10.1371/journal.pone.0242278
|
| 42 |
Jing Wu, Shitong Xie, Yanfang Ma, Xiaoning He, Xinyue Dong, Qianling Shi, Qiangqiang Guo, Qi Wang, Meixuan Li, Naijuan Yao, Liang Yao. Entecavir for children and adults with chronic hepatitis B. Cochrane Database of Systematic Reviews 2023; 2023(2) doi: 10.1002/14651858.CD015536
|
| 43 |
Asaad Mohd, Hiba Sami, Parvez Anwar Khan, Haris M. Khan. A Review on the Epidemiology of HBV and HIV Co-Infection. CHRISMED Journal of Health and Research 2023; 10(1): 1 doi: 10.4103/cjhr.cjhr_34_22
|
| 44 |
Yeshambel Belyhun, Uwe Gerd Liebert, Melanie Maier, Jason Blackard. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia. PLOS ONE 2018; 13(2): e0191970 doi: 10.1371/journal.pone.0191970
|
| 45 |
Darcy Wooten, Maile Y. Karris. The As and Bs of HIV and Hepatitis Co-Infection. Tropical Medicine and Infectious Disease 2019; 4(2): 55 doi: 10.3390/tropicalmed4020055
|
| 46 |
Emma Kaplan-Lewis, Judith A. Aberg, Mikyung Lee. Aging with HIV in the ART era. Seminars in Diagnostic Pathology 2017; 34(4): 384 doi: 10.1053/j.semdp.2017.04.002
|
| 47 |
Mohammad Khalid Parvez. HBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches. World Journal of Hepatology 2015; 7(1): 121-126 doi: 10.4254/wjh.v7.i1.121
|
| 48 |
Keri N Althoff, Kelly A Gebo, Richard D Moore, Cynthia M Boyd, Amy C Justice, Cherise Wong, Gregory M Lucas, Marina B Klein, Mari M Kitahata, Heidi Crane, Michael J Silverberg, M John Gill, William Christopher Mathews, Robert Dubrow, Michael A Horberg, Charles S Rabkin, Daniel B Klein, Vincent Lo Re, Timothy R Sterling, Fidel A Desir, Kenneth Lichtenstein, James Willig, Anita R Rachlis, Gregory D Kirk, Kathryn Anastos, Frank J Palella, Jennifer E Thorne, Joseph Eron, Lisa P Jacobson, Sonia Napravnik, Chad Achenbach, Angel M Mayor, Pragna Patel, Kate Buchacz, Yuezhou Jing, Stephen J Gange. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet HIV 2019; 6(2): e93 doi: 10.1016/S2352-3018(18)30295-9
|
| 49 |
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton, Mark W Sonderup. Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2022; 7(11): 1036 doi: 10.1016/S2468-1253(22)00041-3
|
| 50 |
Yasser Farid, Charlotte Martin, Marc Delforge, Stephane De Wit. Epidemiology and clinical management of HIV-HBV coinfected patients in a large AIDS Reference Center in Belgium. Acta Clinica Belgica 2019; 74(6): 424 doi: 10.1080/17843286.2018.1554292
|
| 51 |
Sagarika Shahriar, Yusha Araf, Rasel Ahmad, Pravakar Kattel, Ganga Sagar Sah, Tanjim Ishraq Rahaman, Rahila Zannat Sadiea, Shahnaj Sultana, Md. Sayeedul Islam, Chunfu Zheng, Md. Golzar Hossain. Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment. Frontiers in Microbiology 2022; 12 doi: 10.3389/fmicb.2021.780887
|
| 52 |
Hussein Mukasa Kafeero, Dorothy Ndagire, Ponsiano Ocama, Abdul Walusansa, Hakim Sendagire. Sero-prevalence of human immunodeficiency virus–hepatitis B virus (HIV–HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis. Virology Journal 2020; 17(1) doi: 10.1186/s12985-020-01443-6
|
| 53 |
G Mena, AL García-Basteiro, JM Bayas. Hepatitis B and A vaccination in HIV-infected adults: A review. Human Vaccines & Immunotherapeutics 2015; 11(11): 2582 doi: 10.1080/21645515.2015.1055424
|
| 54 |
Betty Mwesigwa, Fredrick Sawe, Janet Oyieko, Joel Mwakisisile, Edna Viegas, Gideon Akindiran Akintunde, Josphat Kosgei, Afoke Kokogho, Nyanda Ntinginya, Ilesh Jani, Georgi Shukarev, Jay W Hooper, Steven A Kwilas, Lucy A Ward, Janice Rusnak, Callie Bounds, Rachel Overman, Christopher S Badorrek, Leigh Anne Eller, Michael A Eller, Christina S Polyak, Amber Moodley, Chi L Tran, Margaret C Costanzo, David J Leggat, Dominic Paquin-Proulx, Prossy Naluyima, Dickson Nkafu Anumendem, Auguste Gaddah, Kerstin Luhn, Jenny Hendriks, Chelsea McLean, Macaya Douoguih, Hannah Kibuuka, Merlin L Robb, Cynthia Robinson, Julie A Ake. Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without Human Immunodeficiency Virus in Africa. Clinical Infectious Diseases 2024; doi: 10.1093/cid/ciae215
|
| 55 |
Zhimeng Cheng, Panpan Lin, Nansheng Cheng. HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.713981
|
| 56 |
Kai-Wen Li, Anna Kramvis, Shujia Liang, Xiang He, Qin-Yan Chen, Chao Wang, Qing-Li Yang, Li-Ping Hu, Hui-Hua Jia, Zhong-Liao Fang. Higher prevalence of cancer related mutations 1762T/1764A and PreS deletions in hepatitis B virus (HBV) isolated from HBV/HIV co-infected compared to HBV-mono-infected Chinese adults. Virus Research 2017; 227: 88 doi: 10.1016/j.virusres.2016.10.002
|
| 57 |
Loredana Sarmati, Vincenzo Malagnino. HBV Infection in HIV-Driven Immune Suppression. Viruses 2019; 11(11): 1077 doi: 10.3390/v11111077
|
| 58 |
Marina Pedroso Oliveira, Pollyanne Sousa Lemes, Márcia Alves Dias Matos, Nativa Helena Alves Del‐Rios, Megmar Aparecida Santos Carneiro, Ágabo Macedo Costa Silva, Carmen Luci Rodrigues Lopes, Sheila Araújo Teles, Rodrigo Sebba Aires, Bárbara Vieira Lago, Natalia Motta Araujo, Regina Maria Bringel Martins. Overt and occult hepatitis B virus infection among treatment‐naïve HIV‐infected patients in Brazil. Journal of Medical Virology 2016; 88(7): 1222 doi: 10.1002/jmv.24462
|
| 59 |
Ruth M. Lunn, Gloria D. Jahnke, Charles S. Rabkin. Tumour virus epidemiology. Philosophical Transactions of the Royal Society B: Biological Sciences 2017; 372(1732): 20160266 doi: 10.1098/rstb.2016.0266
|
| 60 |
Laura Ambra Nicolini, Federica Magne, Alessio Signori, Antonio Di Biagio, Laura Sticchi, Chiara Paganino, Paolo Durando, Claudio Viscoli. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course. AIDS Research and Human Retroviruses 2018; 34(11): 922 doi: 10.1089/aid.2017.0070
|
| 61 |
Liping Chen, Shaoping Huang, Jingmao Yang, Xin Cheng, Zhiyin Shang, Hongzhou Lu, Jilin Cheng. Clinical characteristics in patients with SARS‐CoV‐2/HBV co‐infection. Journal of Viral Hepatitis 2020; 27(12): 1504 doi: 10.1111/jvh.13362
|
| 62 |
Vanda dos Muchangos, Lucia Chambal, Charlotta Nilsson, Esperança Sevene, Isabelle Chemin. HIV and hepatitis B virus co-infection in Mozambique: Policy review and health professionals’ knowledge and practices. PLOS ONE 2024; 19(8): e0301305 doi: 10.1371/journal.pone.0301305
|
| 63 |
Jia-Juen Lin, Kuan-Yin Lin, Hung-Jen Tang, Shih-Ping Lin, Yi-Chien Lee, Chun-Eng Liu, Yu-Shan Huang, Ning-Chi Wang, Chia-Wen Li, Wen-Chien Ko, Hao-Jan Yang, Yuan-Ti Lee, Chien-Ching Hung. Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan. Journal of Microbiology, Immunology and Infection 2021; 54(2): 228 doi: 10.1016/j.jmii.2019.10.005
|
| 64 |
Leonardo Weissmann, Camila de Melo Picone, Michele Soares Gomes Gouvêa, Paulo Roberto Abrão Ferreira, Mônica Salum Valverde Borsoi Viana, João Renato Rebello Pinho, Alex Jones Flores Cassenote, Aluísio Cotrim Segurado. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy. The Brazilian Journal of Infectious Diseases 2019; 23(6): 441 doi: 10.1016/j.bjid.2019.10.002
|